InVivoMAb anti-mouse NKG2D (CD314)

Wang D, Gu X, Liu X, et al. NK cells inhibit anti-Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model. Cell Microbiol. 2018,20(7):e12833. doi: 10.1111/cmi.12833

Hosomi S, Grootjans J, Tschurtschenthaler M, et al. Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation. J Exp Med. 2017,214(10):2985-2997. doi: 10.1084/jem.20162041

Yang D, Tian Z, Zhang M, et al. NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus. Sci Rep. 2017,7(1):1288. doi: 10.1038/s41598-017-01379-y

Kjellev S, Haase C, Lundsgaard D, et al. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eur J Immunol. 2007,37(5):1397-406.

Ogasawara K, Hamerman JA, Ehrlich LR, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity. 2004,20(6):757-67.